• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,166
2,283
1,853
1,828
1,712

COUNTRY

871
643
263
249
208

CATEGORIES

  • 856
  • 184
  • 950
  • 1,126
    • 99
  • 385
  • 270
  • 252
  • 65
  • 379
  • 673
  • 1,276
  • 1,621
  • 625
  • 883
  • 1,674
  • 2,641
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 505
  • 726
  • 0
  • 97

PRICE

6,962
11,316
17,033
24,701

PUBLISHED

1,528
2,360
6,744
24,701

PRODUCT TYPE

20,325
3,174
857
164
74
44
21
21
14
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Bronchopulmonary Dysplasia - Pipeline Review, H1 2013 Bronchopulmonary Dysplasia - Pipeline Review, H1 2013 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Pipeline Review, H1 2013

Bronchopulmonary Dysplasia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Bronchopulmonary Dysplasia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM
Neuroendocrine Tumors - Pipeline Review, H1 2013 Neuroendocrine Tumors - Pipeline Review, H1 2013 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Review, H1 2013

Neuroendocrine Tumors – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Neuroendocrine Tumors - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Choroidal Neovascularization - Pipeline Review, H1 2013 Choroidal Neovascularization - Pipeline Review, H1 2013 - Product Thumbnail Image

Choroidal Neovascularization - Pipeline Review, H1 2013

Choroidal Neovascularization – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Choroidal Neovascularization - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM
Streptococcal Infections - Pipeline Review, H1 2013 Streptococcal Infections - Pipeline Review, H1 2013 - Product Thumbnail Image

Streptococcal Infections - Pipeline Review, H1 2013

Streptococcal Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Streptococcal Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Thymus Cancer - Pipeline Review, H1 2013 Thymus Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Thymus Cancer - Pipeline Review, H1 2013

Thymus Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Thymus Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Athlete's Foot (Tinea Pedis) - Pipeline Review, H1 2013 Athlete's Foot (Tinea Pedis) - Pipeline Review, H1 2013 - Product Thumbnail Image

Athlete's Foot (Tinea Pedis) - Pipeline Review, H1 2013

Athlete's Foot (Tinea Pedis) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Athlete's Foot (Tinea Pedis) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM
Metastatic Lung Cancer - Pipeline Review, H1 2013 Metastatic Lung Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Lung Cancer - Pipeline Review, H1 2013

'Metastatic Lung Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Metastatic Lung...

April 2013
FROM
Rabies - Pipeline Review, H1 2013 Rabies - Pipeline Review, H1 2013 - Product Thumbnail Image

Rabies - Pipeline Review, H1 2013

Rabies – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Rabies - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

April 2013
FROM
Burns - Pipeline Review, H1 2013 Burns - Pipeline Review, H1 2013 - Product Thumbnail Image

Burns - Pipeline Review, H1 2013

Burns – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Burns - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

April 2013
FROM
Psychiatric Disorders - Pipeline Review, H1 2013 Psychiatric Disorders - Pipeline Review, H1 2013 - Product Thumbnail Image

Psychiatric Disorders - Pipeline Review, H1 2013

Psychiatric Disorders – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Psychiatric Disorders - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
The Hepatitis C Market Outlook to 2022 The Hepatitis C Market Outlook to 2022 - Product Thumbnail Image

The Hepatitis C Market Outlook to 2022

A patient-based approach utilizing epidemiology data, and primary research in physicians has been utilized to estimate the size of hepatitis C sales across the US, Japan, and five major EU markets The...

April 2013
FROM
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2013 Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2013 - Product Thumbnail Image

Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2013

Interstitial Cystitis (Painful Bladder Syndrome) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2013', provides...

April 2013
FROM
Friedreich Ataxia - Pipeline Review, H1 2013 Friedreich Ataxia - Pipeline Review, H1 2013 - Product Thumbnail Image

Friedreich Ataxia - Pipeline Review, H1 2013

Friedreich Ataxia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Friedreich Ataxia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Partial Seizure - Pipeline Review, H1 2013 Partial Seizure - Pipeline Review, H1 2013 - Product Thumbnail Image

Partial Seizure - Pipeline Review, H1 2013

Partial Seizure – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Partial Seizure - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013 B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013

B-Cell Chronic Lymphocytic Leukemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM
Uterine Cancer - Pipeline Review, H1 2013 Uterine Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Uterine Cancer - Pipeline Review, H1 2013

Uterine Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Uterine Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Sarcopenia - Pipeline Review, H1 2013 Sarcopenia - Pipeline Review, H1 2013 - Product Thumbnail Image

Sarcopenia - Pipeline Review, H1 2013

Sarcopenia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Sarcopenia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Secondary Hyperparathyroidism - Pipeline Review, H1 2013 Secondary Hyperparathyroidism - Pipeline Review, H1 2013 - Product Thumbnail Image

Secondary Hyperparathyroidism - Pipeline Review, H1 2013

Secondary Hyperparathyroidism – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Secondary Hyperparathyroidism - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM
Gram-Positive Bacterial Infections - Pipeline Review, H1 2013 Gram-Positive Bacterial Infections - Pipeline Review, H1 2013 - Product Thumbnail Image

Gram-Positive Bacterial Infections - Pipeline Review, H1 2013

Gram-Positive Bacterial Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gram-Positive Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM
Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013 Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013

Waldenstrom Macroglobulinemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos